Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation

Bone

Volumn 31, Issue 6, 2002, Pages 661-669

  Van der Horst, G ^a   Van Bezooijen, R L ^a   Deckers, M M L ^a   Hoogendam, J ^a   Visser, A ^a   Lowik C W G M ^a   Karperien, M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BMP antagonists; BMP receptors; Bone morphogenetic proteins (BMPs); Mineralization; Osteoblastic differentiation

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; MESSENGER RNA; NOGGIN; PHOSPHATASE; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; AUTOCRINE COMMUNICATION; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OSTEOBLASTS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; STEM CELLS; XENOPUS PROTEINS;

EID: 0036957713     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00903-1     Document Type: Article

References (42)

1. Abe E., Yamamoto M., Taguchi Y., Lecka-Czernik B., O'Brien C.A., Economides A.N., Stahl N., Jilka R.L., Manolagas S.C. Essential requirement of BMP 2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice Antagonism by noggin. J Bone Miner Res. 15:2000;663-673.
2. Akiyama S., Katagiri T., Namiki M., Yamaji N., Yamamoto N., Miyama K., Shibuya H., Ueno N., Wozney J.M., Suda T. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp Cell Res. 235:1997;362-369.
3. Asahina I., Sampath T.K., Nishimura I., Hauschka P.V. Human osteogenic protein 1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol. 123:1993;921-933.
4. Aspenberg P., Jeppson C., Economides A.N. The bone morphogenetic proteins antagonist Noggin inhibits membranous ossification. J Bone Miner Res. 16:2001;497-500.
5. van Bezooijen R.L., Farih-Sips H., Papapoulos S.E., Lowik C.W.G.M. IL-1a. IL-1b, IL-6 and TNF-α steady state mRNA levels analyzed by reverse transcriptase competitive PCR in bone marrow of gonadectomized mice. J Bone Miner Res. 13:1998;185-194.
6. Chen D., Harris M.A., Rossini G., Dunstan C.R., Dallas S.L., Feng J.Q., Mundy G.R., Harris S.E. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int. 60:1997;283-290.
7. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., Rosen V., Mundy G.R., Harris S.E. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol. 142:1998;295-305.
8. Chen S., Guttridge D.C., Tang E., Shi S., Guan K., Wang C.Y. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling. J Biol Chem. 276:2001;39259-39263.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
10. Daluiski A., Engstrand T., Bahamonde M.E., Gamer L.W., Agius E., Stevenson S.L., Cox K., Rosen V., Lyons K.M. Bone morphogenetic protein 3 is a negative regulator of bone density. Nature Genet. 27:2001;84-88.
11. Dang, Z. C., Van Bezooijen, R. L., Karperien, M., Papapoulos, S. E., and Lowik, C. W. G. M. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 17:XXX-XXX; 2002.
12. Deckers M.M.L., Karperien M., van der Bent C., Yamashita T., Papapoulos S.E., Lowik C.W.G.M. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology. 141:2000;1667-1674.
13. DiLeone R.J., King J.A., Storm E.E., Copeland N.G., Jenskins N.A., Kingsley D.M. The Bmp8 gene is expressed in developing skeletal tissue and maps near the Achondroplasia locus on mouse chromosome 4. Genomics. 40:1996;196-198.
14. Ducy P., Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 57:2000;2207-2214.
15. Funaba M., Ogawa K., Abe M. Expression and localization of activin receptors during endochondral bone development. Eur J Endocrinol. 144:(1):2001;63-71.
16. Gomes W.A., Kessler J.A. Msx-2 and p21 mediate the pro-apoptotic but not the anti-proliferative effects of BMP4 on cultured sympathetic neuroblasts. Dev Biol. 237:2001;212-221.
17. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., Wang H., Cundy T., Glorieux F.H., Lev D., Zacharin M., Oexle K., Marcelino J., Suwairi W., Heeger S., Sabatakos G., Apte S., Adkins W.N., Allgrove J., Arslan-Kirchner M., Batch J.A., Beighton P., Black G.C., Boles R.G., Boon L.M., Borrone C., Brunner H.G., Carle G.F., Dallapiccola B., De Paepe A., Floege B., Halfhide M.L., Hall B., Hennekam R.C., Hirose T., Jans A., Juppner H., Kim C.A., Keppler-Noreuil K., Kohlschuetter A., LaCombe D., Lambert M., Lemyre E., Letteboer T., Peltonen L., Ramesar R.S., Romanengo M., Somer H., Steichen-Gersdorf E., Steinmann B., Sullivan B., Superti-Furga A., Swoboda W., van den Boogaard M.J., Van Hul W., Vikkula M., Votruba M., Zabel B., Garcia T., Baron R., Olsen B.R., Warman M.L. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 107:(4):2001;513-523.
18. Groeneveld E.H.J., Burger E.H. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol. 142:2000;9-21.
19. Harris S.E., Sabatini M., Harris M.A., Feng J.Q., Wozney J.M., Mundy G.R. Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells. J Bone Miner Res. 9:1994;389-394.
20. Hay E., Lemonnier J., Fromigue O., Marie P.J. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem. 31:2001;29028-29036.
21. Hock J.M., Krishnan V., Onyia J.E., Bidwell J.P., Milas J., Stanislaus D. Osteoblast apoptosis and bone turnover. J Bone Miner Res. 16:2001;975-984.
22. Hsu D.R., Economides A.N., Wang X., Eimon P.M., Harland R.M. The Xenopus dorsalizing factor gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Molec Cell. 1:1998;673-683.
23. Hughes F.J., Collyer J., Stanfield M., Goodman S.A. The effects of bone morphogenetic protein-2, -4 and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology. 136:1995;2671-2677.
24. Izumi M., Fujio Y., Kunisada K., Negoro S., Tone E., Funamoto M., Osugi T., Oshima Y., Nakaoka Y., Kishimoto T., Yamauchi-Takihara K., Hirota H. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway. J Biol Chem. 276:2001;31133-31141.
25. Kaps C., Lauber J., Ju W., Czichos S., Gross G. The recombinant expression of bone morphogenetic protein type IA receptor (Alk3) in mesenchymal progenitors C3H10T1/2 is sufficient for osteo-/chondrogenic development. Biochem Soc Trans. 26:1998;27-32.
26. Liu F., Ventura F., Doody J., Massague J. Human type II receptor for bone morphogenetic proteins (BMPs) extension of the two kinase receptor model to the BMPs. Mol Cell Biol. 15:1995;3479-3486.
27. Namiki M., Akiyama S., Katagiri T., Suzuki A., Ueno N., Yamaji N., Rosen V., Wozney J.M., Suda T. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem. 272:1997;22046-22052.
28. Okubo Y., Bessho K., Fujimura K., Iizuka T., Miyatake S. Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem Biophys Res Commun. 262:1999;739-743.
29. Piek, E., Heldin, C. H., and ten Dijke, P. Specificity, diversity and regulation in TGF-β superfamily signaling. FASEB J XX: 2105-2124; 2000.
30. Schiller P.C., D'Ippolito G., Roos B.A., Howard G.A. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res. 14:1999;1504-1512.
31. Shukunami C., Akiyama H., Nakamura K., Hiraki Y. Requirements of autocrine signaling by bone morphogenetic protein 4 for chondrogenic differentiation of ATDC5 cells. Fed Eur Bone Lett. 469:2000;83-87.
32. Stein G.S., Lian J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocrine Rev. 14:1993;424-442.
33. Suzawa M., Takeuchi Y., Fukumoto S., Kato S., Ueno N., Miyazono K., Matsumoto T., Fujita T. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology. 140:1999;2125-2133.
34. Takuwa Y., Ohse C., Wang E.A., Wozney J.M., Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun. 174:1991;96-101.
35. Wada Y., Kataoka H., Yokose S., Ishizuya T., Miyazono K., Gao Y.-H., Shibisaki Y., Yamaguchi A. Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. Bone. 22:1998;479-485.
36. Yamaguchi A., Ishizuya T., Kintou N., Wada Y., Katagiri T., Wozney J.M., Rosen V., Yoshiki S. Effects of BMP 2, BMP 4 and BMP 6 on osteoblastic differentiation of bone marrow derived stromal cell lines ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun. 220:1996;366-371.
37. Yamamoto N., Akiyama S., Katagiri T., Namiki M., Kurokawa T., Suda T. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun. 238:1997;574-580.
38. Yamashita T., Ishii H., Shimoda K., Sampath T.K., Katagiri T., Wada M., Osawa T., Suda T. Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4. Bone. 19:1996;429-436.
39. Yeh L.C., Unda R., Lee J.C. Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol. 185:(1):2000;87-97.
40. Zhao G.-Q., Deng K., Labosky P.A., Liaw L., Hogan B.L.M. The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev. 10:1996;1657-1669.
41. Zhao G.-Q., Liaw L., Hogan B.L.M. Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis. Development. 125:1998;1103-1112.
42. Zimmerman L.B., Jesus-Escobar J.M., Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 86:1996;599-606.